Eton Pharmaceuticals (ETON) Research & Development (2018 - 2026)
Eton Pharmaceuticals (ETON) reported Research & Development of $993,000 for Q2 2026, down 73.2% from $3.71 million a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Research & Development (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eton Pharmaceuticals' Research & Development came in at $7.6 million, up 68.6% year-over-year; for FY2025, it came in at $7.77 million, up 138.6% from FY2024.
- Research & Development has a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
- By year, Research & Development came in at $3.26 million in FY2024 (-2.0%), $3.32 million in FY2023 (-16.9%), $4 million in FY2022 (-35.9%) and $6.24 million in FY2021 (-55.8%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q4 2024.
- Year over year, Research & Development gained in three of the last five quarters, with growth averaging 26.5%.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 164.0%); the low point was Q4 2021 (a decline of 80.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Eton Pharmaceuticals | 1.39 Bn | 1.27 Bn | 25.41 Mn | 993,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 993,000.00 |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | -871,000.00 |
| Sep 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 651,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 615,000.00 |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 535,000.00 |
| Dec 31, 2022 | 944,000.00 |
| Sep 30, 2022 | 744,000.00 |
| Jun 30, 2022 | 690,000.00 |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 681,000.00 |
| Sep 30, 2021 | 2.68 Mn |
| Jun 30, 2021 | 1.99 Mn |
API Access
Eton Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();